REPRISE: tolvaptan in advanced polycystic kidney disease
- PMID: 29389391
- DOI: 10.1016/j.kint.2017.12.002
REPRISE: tolvaptan in advanced polycystic kidney disease
Erratum in
-
Wyatt CM, Le Meur Y. REPRISE: tolvaptan in advanced polycystic kidney disease. Kidney Int. 2018;93:292-295.Kidney Int. 2018 Apr;93(4):1019. doi: 10.1016/j.kint.2018.02.001. Kidney Int. 2018. PMID: 29571442 No abstract available.
Keywords: ADPKD; chronic kidney disease; vasopressin.
Comment on
-
Tolvaptan in Later-Stage Autosomal Dominant Polycystic Kidney Disease.N Engl J Med. 2017 Nov 16;377(20):1930-1942. doi: 10.1056/NEJMoa1710030. Epub 2017 Nov 4. N Engl J Med. 2017. PMID: 29105594 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources